7SMU

Crystal Structure of Consomatin-Ro1 <structure_details=Consomatin-Ro1, a cone snail venom SSTL mimetic


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.95 Å
  • R-Value Free: 0.282 
  • R-Value Work: 0.236 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads.

Ramiro, I.B.L.Bjorn-Yoshimoto, W.E.Imperial, J.S.Gajewiak, J.Salcedo, P.F.Watkins, M.Taylor, D.Resager, W.Ueberheide, B.Brauner-Osborne, H.Whitby, F.G.Hill, C.P.Martin, L.F.Patwardhan, A.Concepcion, G.P.Olivera, B.M.Safavi-Hemami, H.

(2022) Sci Adv 8: eabk1410-eabk1410

  • DOI: https://doi.org/10.1126/sciadv.abk1410
  • Primary Citation of Related Structures:  
    7SMU

  • PubMed Abstract: 

    Somatostatin (SS) is a peptide hormone with diverse physiological roles. By investigating a deep-water clade of fish-hunting cone snails, we show that predator-prey evolution has generated a diverse set of SS analogs, each optimized to elicit specific systemic physiological effects in prey. The increased metabolic stability, distinct SS receptor activation profiles, and chemical diversity of the venom analogs make them suitable leads for therapeutic application, including pain, cancer, and endocrine disorders. Our findings not only establish the existence of SS-like peptides in animal venoms but also serve as a model for the synergy gained from combining molecular phylogenetics and behavioral observations to optimize the discovery of natural products with biomedical potential.


  • Organizational Affiliation

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen-N 2200, Denmark.


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Consomatin-Ro113Conus rolaniMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
V1J (Subject of Investigation/LOI)
Query on V1J

Download Ideal Coordinates CCD File 
G [auth D]3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxaoctatetracontane-1,48-diol
C33 H68 O17
UQGCHKWTTDVZHM-UHFFFAOYSA-N
Modified Residues  2 Unique
IDChains TypeFormula2D DiagramParent
CGU
Query on CGU
A [auth D]
B [auth E]
C
D [auth B]
E [auth F]
A [auth D],
B [auth E],
C,
D [auth B],
E [auth F],
F [auth A]
L-PEPTIDE LINKINGC6 H9 N O6GLU
HYP
Query on HYP
A [auth D]
B [auth E]
C
D [auth B]
E [auth F]
A [auth D],
B [auth E],
C,
D [auth B],
E [auth F],
F [auth A]
L-PEPTIDE LINKINGC5 H9 N O3PRO
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.95 Å
  • R-Value Free: 0.282 
  • R-Value Work: 0.236 
  • Space Group: P 65 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 50.282α = 90
b = 50.282β = 90
c = 135.005γ = 120
Software Package:
Software NamePurpose
XDSdata reduction
Aimlessdata scaling
SOLVEphasing
RESOLVEphasing
REFMACrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Department of Defense (DOD, United States)PR161686

Revision History  (Full details and data files)

  • Version 1.0: 2022-04-13
    Type: Initial release